Last reviewed · How we verify
NCT06031675
Mechanism for Exercise to Delay Cardiac Aging
trial testing Vigorous intermittent lifestyle physical activity in Activity, Motor in 40 participants. Completed in 1 September 2023.
10 July 2023
Quick facts
| Lead sponsor | Xiao-dong Zhuang |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 12 May 2023 |
| Primary completion | 10 July 2023 |
| Estimated completion | 1 September 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Vigorous intermittent lifestyle physical activity
Conditions studied
- Activity, Motor — all drugs for Activity, Motor →
- Health Behavior — all drugs for Health Behavior →
Sponsor
Xiao-dong Zhuang
Who can join
18 and older, any sex, with Activity, Motor or Health Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinicaltrial is to assess and compare isokinetic performance, surface electromyography, laboratory parameters, and cardiorespiratory function both before and after engaging in vigorous intermittent lifestyle physical activity(VILPA) within a healthy population. The main question it aims to answer is: \[1\] Does VILPA yield effective outcomes? Throughout the course of the trial, participants will engage in a simulated regimen of vigorous intermittent lifestyle physical activity for a duration of 8 weeks. The efficacy of the exercise protocol will be quantified and evaluated through the utilization of a wearable device.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06031675
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Vigorous intermittent lifestyle physical activity
Trials testing the same drug.
- NCT06259370 — Benefits of VILPA in Young Adults · NA · completed
Other recruiting trials for Activity, Motor
Currently open trials in the same condition.
- NCT07378826 — Power Training Progression Methods · NA · recruiting
- NCT07378813 — Low Versus High Load Training and Parkinson's Disease · NA · recruiting
- NCT07141849 — Periodization and Parkinson's Disease · NA · recruiting
- NCT06821321 — Power or Plyometric Training in Older Adults · NA · recruiting
- NCT06489262 — Efficacy Trial of Healthy Together ("Juntos") · NA · recruiting
Other Xiao-dong Zhuang trials
Trials by the same sponsor.
- NCT06814210 — CAP-TEER: CerebrAl Protection During Transcatheter Edge-to-edge Repair · NA · not yet recruiting
- NCT06762145 — EArly Effect of Glucocorticoid on Incidence of Persistent Left BundlE Branch Block (LBBB) Post-TAVR (EAGLE-TAVR Trial) · Phase 4 · not yet recruiting
- NCT06386016 — Detection of Valvular Heart Disease Using Artificial Intelligence-based Stethoscope · recruiting
- NCT06259370 — Benefits of VILPA in Young Adults · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06031675 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xiao-dong Zhuang
- Last refreshed: 11 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06031675.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing